OREXIGEN THERAPEUTICS
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is ... a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
OREXIGEN THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.orexigen.com
Total Employee:
101+
Status:
Active
Contact:
(858) 875-8600
Email Addresses:
[email protected]
Total Funding:
301 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS Microsoft Amazon Ohio Region
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
The Baupost Group
The Baupost Group investment in Post-IPO Equity - Orexigen Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Orexigen Therapeutics
Wasatch Advisors
Wasatch Advisors investment in Series C - Orexigen Therapeutics
MPM Capital
MPM Capital investment in Series C - Orexigen Therapeutics
Montreux Equity Partners
Montreux Equity Partners investment in Series B - Orexigen Therapeutics
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Orexigen Therapeutics
Duke University
Duke University investment in Series B - Orexigen Therapeutics
Domain Associates
Domain Associates investment in Series B - Orexigen Therapeutics
Greenspring Associates
Greenspring Associates investment in Series B - Orexigen Therapeutics
Scale Venture Partners
Scale Venture Partners investment in Series B - Orexigen Therapeutics
Official Site Inspections
http://www.orexigen.com
- Host name: 209.17.116.163
- IP address: 209.17.116.163
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Orexigen Therapeutics"
Orexigen Therapeutics - Wikipedia
Orexigen Therapeutics, Inc. is a public American pharmaceutical company focused on development of treatments for obesity. [1] The company is based in La Jolla, California and …See details»
Orexigen Therapeutics - Crunchbase Company Profile …
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has …See details»
Orexigen Therapeutics, Inc. Company Profile | La Jolla, CA ...
Company Description: Orexigen Therapeutics believed it had the skinny on how to stay trim. The company developed drugs intended for use by obese people who are trying to get a grip on …See details»
Orexigen Therapeutics Company Profile 2024: …
Orexigen Therapeutics General Information Description. Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older drugs seeking synergistic actions.See details»
Orexigen Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
The partners plan to send out a questionnaire to members of the organization’s community to learn more about how they experience food noise.“We’ve heard from so many people living …See details»
Orexigen Therapeutics, Inc. - VentureRadar
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Orexigen’s first medicine, Contrave® (naltrexone HCl and bupropion HCl extended release), …See details»
Orexigen Therapeutics - Products, Competitors, Financials, …
Orexigen Therapeutics operates a public pharmaceutical company. The company focuses on the development of pharmaceutical products for the treatment of central nervous system (CNS) …See details»
Orexigen Therapeutics Company Overview, Contact Details
Mar 29, 2016 Revenue Potential Orexigen Therapeutics has a revenue range of $10M - 50M, indicating a solid financial standing and potential opportunities for partnership or collaboration.. …See details»
Orexigen Therapeutics, Inc. (OREX) - Yahoo Finance Canada
See the company profile for Orexigen Therapeutics, Inc. (OREX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Company Orexigen Therapeutics, Inc. Other OTC
Orexigen Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the treatment of obesity. The Company's product, Contrave, is approved in the United States by …See details»
Orexigen Therapeutics - Craft
Orexigen Therapeutics is a biopharmaceutical company which focuses on the development of pharmaceutical product candidates for the treatment of obesity. The Company's product, …See details»
Orexigen Therapeutics - Contacts, Employees, Board Members
Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. …See details»
Organization | Orexigen Therapeutics, Inc
Orexigen Therapeutics, Inc Report issue. For profit Phase 1 Phase 2 Phase 4. Founded: La Jolla CA United States (2002 ... Organization Overview. First Clinical Trial. 2005 NCT00364871. …See details»
Orexigen Therapeutics, Inc. (OREX) - Yahoo Finance
See the company profile for Orexigen Therapeutics, Inc. (OREX), including business summary, industry/sector information, number of employees, corporate governance, key executives and …See details»
Orexigen Therapeutics: Employee Directory | ZoomInfo.com
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers …See details»
Company Orexigen Therapeutics, Inc. Deutsche Boerse AG
Orexigen Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the treatment of obesity. The Company's product, Contrave, is approved in the United States by …See details»
Orexigen Case Study - GlobalSign
Efficiencies of the organization - an important factor in the increasingly competitive pharmaceutical industry. By adopting Adobe CDS by GlobalSign, Orexigen can now securely and easily sign, …See details»
What is Orexigen Therapeutics? Company Culture, Mission, Values
Orexigen Therapeutics. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. …See details»